1. Home
  2. CWCO vs MYGN Comparison

CWCO vs MYGN Comparison

Compare CWCO & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consolidated Water Co. Ltd.

CWCO

Consolidated Water Co. Ltd.

HOLD

Current Price

$28.99

Market Cap

478.2M

Sector

Utilities

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

N/A

Current Price

$3.20

Market Cap

444.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CWCO
MYGN
Founded
1973
1991
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Water Supply
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
478.2M
444.2M
IPO Year
1997
1996

Fundamental Metrics

Financial Performance
Metric
CWCO
MYGN
Price
$28.99
$3.20
Analyst Decision
Strong Buy
Buy
Analyst Count
1
7
Target Price
$40.00
$7.64
AVG Volume (30 Days)
71.9K
1.8M
Earning Date
05-11-2026
05-05-2026
Dividend Yield
1.73%
N/A
EPS Growth
N/A
N/A
EPS
0.48
N/A
Revenue
$132,073,368.00
$771,400,000.00
Revenue This Year
$4.34
$6.86
Revenue Next Year
$42.86
$5.45
P/E Ratio
$60.25
N/A
Revenue Growth
N/A
2.33
52 Week Low
$28.17
$2.74
52 Week High
$39.12
$8.59

Technical Indicators

Market Signals
Indicator
CWCO
MYGN
Relative Strength Index (RSI) 40.16 39.24
Support Level $28.78 $2.79
Resistance Level $30.68 $3.31
Average True Range (ATR) 0.78 0.18
MACD -0.16 0.09
Stochastic Oscillator 7.56 69.90

Price Performance

Historical Comparison
CWCO
MYGN

About CWCO Consolidated Water Co. Ltd.

Consolidated Water Co Ltd is a water utility company. It develops and operates seawater desalination plants and water distribution systems. The company's business segments are; The retail segment operates the water utility for the Seven Mile Beach and West Bay areas of Grand Cayman Island, The bulk segment supplies potable water to government utilities in Grand Cayman and The Bahamas under long-term contracts, The services segment designs, constructs and sells water infrastructure and provides management and operating services to third parties. The manufacturing segment manufactures and services a wide range of custom and specialized water-related products applicable to commercial, municipal, and industrial water production, supply, and treatment, and the corporate segment.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: